You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
朗生医药(00503.HK)中期纯利减54.9%至478.3万美元
格隆汇 08-27 22:47

格隆汇8月27日丨朗生医药(00503.HK)公告,截至2019年6月30日止6个月,公司收入同比减少27.2%至2615万美元; 公司拥有人应占溢利同比减少54.9%至478.3万美元;每股基本及摊薄盈利1.2美仙;无派息。

溢利下降,主要受以下因素影响:(1)诚如2018年年报提及,因受中国医药经营政策变化和集团经营策略调整,集团减少代理产品,其中玉泽的代理已经终止,而玉泽在去年上半年仍有录得销售收入;(2)期内有若干存货进行拨备及撇账;及(3)集团于2019年6月21日公告不行使认沽萃健控股有限公司期权,不行使认沽萃健期权令公司录得若干撇销损失。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account